跳至主要内容
临床试验/EUCTR2007-003026-14-AT
EUCTR2007-003026-14-AT进行中(未招募)不适用

/A - Prevention of elastic recoil by urapidil

KA Rudolfstiftung - 2. Medizinische Abteilung0 个研究点目标入组 80 人开始时间: 2008年5月8日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - coronary artery disease with a single coronary vessel requiring intervention
  • - patients of both sexes between 18 and 80 years of age
  • - stable angina pectoris
  • - regular sinus rhythm in electrocardiogram
  • - body weight = 55 kg and = 100 kg
  • - written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - contraindication for the IMP
  • - coronary artery disease with more than one coronary vessels requiring intervention
  • - acute coronary syndrome defined as unstable angina pectoris, ST elevation
  • myocardial infarction (STEMI), and non-ST elevation myocardial infarction (STEMI)
  • - concomitant treatment with the following glycoprotein (GP) IIb/IIIa inhibitors:
  • Abciximab (ReoPro®), Ebtafibatid (Integrilin®), or Tirofiban (Agrastat®)
  • - pacemaker patient or patient with implanted cardiac defibrillator
  • - severe aortic stenosis and/or aortic insufficiency, severe mitral stenosis and/or
  • insufficiency
  • - serum creatinin > 1.5 mg/dl
  • - hypotonia (SBP = 100 mmHg measured in lying position)
  • - at least one of the following events within 3 months prior to enrolment date:
  • myocardial infarction, transient ischemic attack (TIA), prolonged ischemic neurological
  • deficit (PRIND), stroke
  • - cardiac ejection fraction < 35%
  • - NYHA class 3 or higher
  • - concomitant treatment with alpha receptor blocking agents within 6 months
  • prior to enrolment date

研究者

发起方
KA Rudolfstiftung - 2. Medizinische Abteilung

相似试验

/A | 临床试验